ARV-102 is Arvinas' investigational PROteolysis TArgeting Chimera (PROTAC) degrader targeting leucine-rich repeat kinase 2 ...

The world's best clinics achieve success in Parkinson’s treatment by individualizing deep brain stimulation (DBS) through ...

AI-driven software was able to differentiate between typical and atypical forms of Parkinson's disease with 96% accuracy. | ...

Artificial intelligence can significantly reduce the likelihood of Parkinson's disease being misdiagnosed.<br /><br /> ...

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement ...

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five ...

University of Florida researchers have led a multicenter study demonstrating that Automated Imaging Differentiation for ...

The following is a summary of “Automated Imaging Differentiation for Parkinsonism,” published in the March 2025 issue of JAMA ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

The eligibility criteria for a Blue Badge was extended in 2019 to include individuals with non-visible disabilities ...

Across two cohorts, the Automated Imaging Differentiation for Parkinsonism (AIDP) machine learning model distinguished ...

The 22nd Annual CurePSP Awareness and Memorial Walk will take place on March 29th at Mackle Park on Marco Island. The event ...